Analysis of the vasorelaxant action of jatrophone in the isolated aorta of the rat: influence of potassium channel blockers.

[1]  G. Edwards,et al.  Structure-activity relationships of K+ channel openers. , 1990, Trends in pharmacological sciences.

[2]  D. Robertson,et al.  Potassium channel modulators: scientific applications and therapeutic promise. , 1990, Journal of medicinal chemistry.

[3]  Y. Imaizumi,et al.  Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries. , 1990, The Journal of pharmacology and experimental therapeutics.

[4]  O. Petersen,et al.  The effects of cromakalim on ATP‐sensitive potassium channels in insulin‐secreting cells , 1990, British journal of pharmacology.

[5]  J. Henquin,et al.  Effects of putative activators of K+ channels in mouse pancreatic β‐cells , 1989 .

[6]  N. Standen,et al.  Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. , 1989, Science.

[7]  U. Quast,et al.  In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. , 1989, The Journal of pharmacology and experimental therapeutics.

[8]  M. Eltze.  Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery. , 1989, European journal of pharmacology.

[9]  T. Hamilton,et al.  Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat , 1989, British journal of pharmacology.

[10]  I. Cavero,et al.  Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. , 1989, The Journal of pharmacology and experimental therapeutics.

[11]  C. Wilson.  Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro. , 1989, Journal of autonomic pharmacology.

[12]  R. Yunes,et al.  Evaluation of pharmacological activity of a crude hydroalcoholic extract from Jatropha elliptica , 1988 .

[13]  T. Hamilton,et al.  Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil. , 1988, European journal of pharmacology.

[14]  M. Lazdunski,et al.  The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. , 1987, The Journal of biological chemistry.

[15]  J. Calixto,et al.  Pharmacological analysis of the inhibitory effect of jatrophone, a diterpene isolated from Jatropha elliptica, on smooth and cardiac muscles , 1987 .

[16]  C. Hales,et al.  THE SULPHONYLUREA RECEPTOR MAY BE AN ATP-SENSITIVE POTASSIUM CHANNEL , 1985, The Lancet.

[17]  J. Henquin,et al.  Diazoxide and D600 Inhibition of Insulin Release: Distinct Mechanisms Explain the Specificity for Different Stimuli , 1982, Diabetes.

[18]  S. Duckles.  Modulation of endogenous noradrenaline release by prejunctional alpha-adrenoreceptors: comparison of a cerebral and peripheral artery. , 1982, Journal of autonomic pharmacology.

[19]  H. Meissner,et al.  Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells. , 1982, Biochemical pharmacology.

[20]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[21]  T. Godfraind,et al.  Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle , 1969, British journal of pharmacology.

[22]  J. Calixto,et al.  Evidence for the mechanism of the inhibitory action of jatrophone in the isolated rat uterine muscle. , 1990, General pharmacology.

[23]  T. Hamilton,et al.  Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. , 1989, General pharmacology.

[24]  R. Stein,et al.  Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle. , 1989, The Journal of pharmacology and experimental therapeutics.

[25]  N. S. Cook,et al.  The pharmacology of potassium channels and their therapeutic potential. , 1988, Trends in pharmacological sciences.

[26]  G. Weiss,et al.  Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium. , 1968, The Journal of pharmacology and experimental therapeutics.